Minimum order 2 vials or 2 pens — delivery in 2 weeks The first 29 amino acids of GHRH — the shortest piece that keeps ALL of its activity. Approved as a diagnostic, with fewer false positives than the other tests.
Illustrations of the product — not photos of a specific batch.
Sermorelin is the first 29 amino acids of GHRH — the hypothalamic hormone that tells the pituitary to release growth hormone.
It's the shortest synthetic peptide that retains all of GHRH's biological activity 1. It doesn't hand you ready-made hormone — it asks your pituitary to make it itself.
In prepubertal children with idiopathic growth hormone deficiency, dosing before bed significantly increased growth rate, with the improvement holding at 12 months1.
What we don't know yet: the effect on final height remains an open question, and the data on how well gains hold after stopping treatment are preliminary 12.
Research-use product. Lyophilized in the freezer for long-term storage; after reconstitution, fridge and dark.
Sources — 2 published studies
Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157. doi:10.2165/00063030-199912020-00007
Schwartz ID, Grunt JA, Berg S, et al. Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunction. J Pediatr Endocrinol Metab. 2000;13(6):645-650. doi:10.1515/jpem.2000.13.6.645
Sermorelin doesn't hand you the hormone ready-made — it wakes up your own machinery to make it, and there's something beautiful in that.
It's the first 29 amino acids of GHRH, the shortest piece that keeps all of the original's activity 1. The hypothalamus speaks, the pituitary listens.
In children with growth hormone deficiency, the dose before bed significantly increased growth rate — and the improvement held up to 12 months1.
The honest part: the effect on final height hasn't been answered yet, and the data after stopping treatment are still preliminary 12.
Research-use product. Store lyophilized in the freezer; after reconstitution, fridge, dark, swirl never shake.
Sources — 2 published studies
Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157. doi:10.2165/00063030-199912020-00007
Schwartz ID, Grunt JA, Berg S, et al. Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunction. J Pediatr Endocrinol Metab. 2000;13(6):645-650. doi:10.1515/jpem.2000.13.6.645
It doesn't give you hormone. It asks your pituitary to make it.
GHRH is the hypothalamic hormone that tells the pituitary “release growth hormone.” Sermorelin is its first 29 amino acids — and it's the shortest synthetic peptide that retains all of GHRH's biological activity1. Cut any further and you lose it.
Where it's approved, and why. As a diagnostic. An intravenous injection of 1 µg/kg gives a quick and relatively specific test for growth hormone deficiency — and here's the key point: fewer false positives than the other provocative tests 1. In other words, it was a measuring tool before it was a treatment tool.
As a treatment, what the numbers show. 30 µg/kg subcutaneously, once a day before bed: it significantly increased growth rate in prepubertal children with idiopathic deficiency, and the increase held at 12 months — with data from a few children showing it held up to 361.
And now the two sentences you won't find anywhere else. First: at the same dose, 30 µg/kg, the gains with sermorelin were smaller than those of children taking growth hormone itself1. Second, and more serious: in a study of 24 children treated for six months, six months after stopping, growth rate was not significantly different from the pre-treatment rate2.
So: it works while you take it, less than the hormone itself, and leaves nothing banked behind. And what it does to final height remains unknown 1.
In practice: it's given by a simple subcutaneous injection, once a day 1. Pure vial, properly stored — for research use.
Sources — 2 published studies
Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157. doi:10.2165/00063030-199912020-00007
Schwartz ID, Grunt JA, Berg S, et al. Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunction. J Pediatr Endocrinol Metab. 2000;13(6):645-650. doi:10.1515/jpem.2000.13.6.645
Both studies involve children with deficiency or short stature. There's no comparable body of data in healthy adults.
We don't keep it in stock — it's ordered in: minimum 2 items (vials or pens) from the special-order products, with free shipping, and it arrives in about 2 weeks.
How much is shipping?
€3 shipping + €3 cash-on-delivery fee. For orders of 2 vials or pens or more, shipping and the cash-on-delivery fee are free. Delivery time depends on the courier.
How do I pay?
Cash on delivery, paid to the courier when it arrives. For an electronic money transfer (PayPal, Revolut, Wise, crypto), email us for the details: ellinikapeptidia@gmail.com
Can I return it?
Yes: you have a 14-day right of withdrawal from delivery, as long as the seal is intact. Return costs are yours, unless the product was faulty or wrong. Terms of Use
Want something you don't see here? Write to us — we reply.
Related products
From the same category
%OFF
IGF-1 LR3
IGF-1 LR3
from €68.80 to €84.80
Minimum order 2 vials or 2 pens — delivery in 2 weeks
IGF-1 with 13 extra amino acids and one substitution, so the binding proteins DON'T grab it. In the only chronic-infusion study, the internal organs grew — not the body.
Minimum order 2 vials or 2 pens — delivery in 2 weeks
An older-generation growth hormone secretagogue: in a clinical trial it produced a mean peak growth hormone of 25.7 μg/L in GH-sufficient vs 1.3 μg/L in GH-deficient subjects.
Minimum order 2 vials or 2 pens — delivery in 2 weeks
A GRF(1-29) analogue (mod GRF 1-29): the modified sequence gains resistance to dipeptidyl peptidase IV and stays active in growth hormone release in a pituitary assay.